ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Netupitant and Palonosetron Hydrochloride Capsules Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-13E14423
Home | Market Reports | Health| Health Conditions| Cancer
Global Netupitant and Palonosetron Hydrochloride Capsules Market Research Report 2023
BUY CHAPTERS

Global Netupitant and Palonosetron Hydrochloride Capsules Market Research Report 2025

Code: QYRE-Auto-13E14423
Report
May 2025
Pages:69
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
EurimPharm Arzneimittel GmbH
Sichuan Kelun Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co. Ltd
Qilu Pharmaceutical Co. Ltd.
Helsinn Birex Pharmaceuticals Ltd

Netupitant and Palonosetron Hydrochloride Capsules Market

The global market for Netupitant and Palonosetron Hydrochloride Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Netupitant Palonosetron Capsules is a drug for the treatment of chemotherapy-related nausea and vomiting (CINV). It is the world"s first and only dual-channel oral compound drug that inhibits 5-HT3 receptors and NK1 receptors. Block the two key pathways of CINV, effectively antiemetic. At the same time, the convenience of the compound preparation also makes it have significant advantages in improving the compliance of clinicians" guidelines and medication compliance of patients, and improving the management of CINV.
North American market for Netupitant and Palonosetron Hydrochloride Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Netupitant and Palonosetron Hydrochloride Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Netupitant and Palonosetron Hydrochloride Capsules include Helsinn Birex Pharmaceuticals Ltd, Eurimpharm Arzneimittel GmbH, Sichuan Kelun Pharmaceutical Co., Ltd, CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD, QILU PHARMACEUTICAL CO.,LTD, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Netupitant and Palonosetron Hydrochloride Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Netupitant and Palonosetron Hydrochloride Capsules.
The Netupitant and Palonosetron Hydrochloride Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Netupitant and Palonosetron Hydrochloride Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Netupitant and Palonosetron Hydrochloride Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Netupitant and Palonosetron Hydrochloride Capsules Market Report

Report Metric Details
Report Name Netupitant and Palonosetron Hydrochloride Capsules Market
Segment by Type
  • 300 mg/Capsule 1 Capsule/Box
  • 0.5 mg/Capsule 1 Capsule/Box
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Helsinn Birex Pharmaceuticals Ltd, Eurimpharm Arzneimittel GmbH, Sichuan Kelun Pharmaceutical Co., Ltd, CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD, QILU PHARMACEUTICAL CO.,LTD
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Netupitant and Palonosetron Hydrochloride Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Netupitant and Palonosetron Hydrochloride Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Netupitant and Palonosetron Hydrochloride Capsules Market report?

Ans: The main players in the Netupitant and Palonosetron Hydrochloride Capsules Market are Helsinn Birex Pharmaceuticals Ltd, Eurimpharm Arzneimittel GmbH, Sichuan Kelun Pharmaceutical Co., Ltd, CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD, QILU PHARMACEUTICAL CO.,LTD

What are the Application segmentation covered in the Netupitant and Palonosetron Hydrochloride Capsules Market report?

Ans: The Applications covered in the Netupitant and Palonosetron Hydrochloride Capsules Market report are Moderate Emetogenic Chemotherapy, Highly Emetogenic Chemotherapy

What are the Type segmentation covered in the Netupitant and Palonosetron Hydrochloride Capsules Market report?

Ans: The Types covered in the Netupitant and Palonosetron Hydrochloride Capsules Market report are 300 mg/Capsule 1 Capsule/Box, 0.5 mg/Capsule 1 Capsule/Box

Recommended Reports

Capsule Drugs

Cancer Therapeutics

Pharma Packaging & Devices

1 Netupitant and Palonosetron Hydrochloride Capsules Market Overview
1.1 Product Definition
1.2 Netupitant and Palonosetron Hydrochloride Capsules by Type
1.2.1 Global Netupitant and Palonosetron Hydrochloride Capsules Market Value Comparison by Type (2024 VS 2031)
1.2.2 300 mg/Capsule 1 Capsule/Box
1.2.3 0.5 mg/Capsule 1 Capsule/Box
1.3 Netupitant and Palonosetron Hydrochloride Capsules by Application
1.3.1 Global Netupitant and Palonosetron Hydrochloride Capsules Market Value by Application (2024 VS 2031)
1.3.2 Moderate Emetogenic Chemotherapy
1.3.3 Highly Emetogenic Chemotherapy
1.4 Global Netupitant and Palonosetron Hydrochloride Capsules Market Size Estimates and Forecasts
1.4.1 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue 2020-2031
1.4.2 Global Netupitant and Palonosetron Hydrochloride Capsules Sales 2020-2031
1.4.3 Global Netupitant and Palonosetron Hydrochloride Capsules Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Netupitant and Palonosetron Hydrochloride Capsules Market Competition by Manufacturers
2.1 Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Manufacturers (2020-2025)
2.2 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Netupitant and Palonosetron Hydrochloride Capsules Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Netupitant and Palonosetron Hydrochloride Capsules, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Netupitant and Palonosetron Hydrochloride Capsules, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Netupitant and Palonosetron Hydrochloride Capsules, Product Type & Application
2.7 Global Key Manufacturers of Netupitant and Palonosetron Hydrochloride Capsules, Date of Enter into This Industry
2.8 Global Netupitant and Palonosetron Hydrochloride Capsules Market Competitive Situation and Trends
2.8.1 Global Netupitant and Palonosetron Hydrochloride Capsules Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Netupitant and Palonosetron Hydrochloride Capsules Players Market Share by Revenue
2.8.3 Global Netupitant and Palonosetron Hydrochloride Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Netupitant and Palonosetron Hydrochloride Capsules Market Scenario by Region
3.1 Global Netupitant and Palonosetron Hydrochloride Capsules Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Region: 2020-2031
3.2.1 Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Region: 2020-2025
3.2.2 Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Region: 2026-2031
3.3 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Region: 2020-2031
3.3.1 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Region: 2020-2025
3.3.2 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Region: 2026-2031
3.4 North America Netupitant and Palonosetron Hydrochloride Capsules Market Facts & Figures by Country
3.4.1 North America Netupitant and Palonosetron Hydrochloride Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2020-2031)
3.4.3 North America Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Netupitant and Palonosetron Hydrochloride Capsules Market Facts & Figures by Country
3.5.1 Europe Netupitant and Palonosetron Hydrochloride Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2020-2031)
3.5.3 Europe Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Netupitant and Palonosetron Hydrochloride Capsules Market Facts & Figures by Region
3.6.1 Asia Pacific Netupitant and Palonosetron Hydrochloride Capsules Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Netupitant and Palonosetron Hydrochloride Capsules Sales by Region (2020-2031)
3.6.3 Asia Pacific Netupitant and Palonosetron Hydrochloride Capsules Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Netupitant and Palonosetron Hydrochloride Capsules Market Facts & Figures by Country
3.7.1 Latin America Netupitant and Palonosetron Hydrochloride Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2020-2031)
3.7.3 Latin America Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Netupitant and Palonosetron Hydrochloride Capsules Market Facts & Figures by Country
3.8.1 Middle East and Africa Netupitant and Palonosetron Hydrochloride Capsules Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2020-2031)
3.8.3 Middle East and Africa Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Type (2020-2031)
4.1.1 Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Type (2020-2025)
4.1.2 Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Type (2026-2031)
4.1.3 Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Type (2020-2031)
4.2 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Type (2020-2031)
4.2.1 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Type (2020-2025)
4.2.2 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Type (2026-2031)
4.2.3 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Type (2020-2031)
4.3 Global Netupitant and Palonosetron Hydrochloride Capsules Price by Type (2020-2031)
5 Segment by Application
5.1 Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Application (2020-2031)
5.1.1 Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Application (2020-2025)
5.1.2 Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Application (2026-2031)
5.1.3 Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Application (2020-2031)
5.2 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Application (2020-2031)
5.2.1 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Application (2020-2025)
5.2.2 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Application (2026-2031)
5.2.3 Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Application (2020-2031)
5.3 Global Netupitant and Palonosetron Hydrochloride Capsules Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Helsinn Birex Pharmaceuticals Ltd
6.1.1 Helsinn Birex Pharmaceuticals Ltd Company Information
6.1.2 Helsinn Birex Pharmaceuticals Ltd Description and Business Overview
6.1.3 Helsinn Birex Pharmaceuticals Ltd Netupitant and Palonosetron Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Helsinn Birex Pharmaceuticals Ltd Netupitant and Palonosetron Hydrochloride Capsules Product Portfolio
6.1.5 Helsinn Birex Pharmaceuticals Ltd Recent Developments/Updates
6.2 Eurimpharm Arzneimittel GmbH
6.2.1 Eurimpharm Arzneimittel GmbH Company Information
6.2.2 Eurimpharm Arzneimittel GmbH Description and Business Overview
6.2.3 Eurimpharm Arzneimittel GmbH Netupitant and Palonosetron Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eurimpharm Arzneimittel GmbH Netupitant and Palonosetron Hydrochloride Capsules Product Portfolio
6.2.5 Eurimpharm Arzneimittel GmbH Recent Developments/Updates
6.3 Sichuan Kelun Pharmaceutical Co., Ltd
6.3.1 Sichuan Kelun Pharmaceutical Co., Ltd Company Information
6.3.2 Sichuan Kelun Pharmaceutical Co., Ltd Description and Business Overview
6.3.3 Sichuan Kelun Pharmaceutical Co., Ltd Netupitant and Palonosetron Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sichuan Kelun Pharmaceutical Co., Ltd Netupitant and Palonosetron Hydrochloride Capsules Product Portfolio
6.3.5 Sichuan Kelun Pharmaceutical Co., Ltd Recent Developments/Updates
6.4 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD
6.4.1 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Company Information
6.4.2 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Description and Business Overview
6.4.3 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Netupitant and Palonosetron Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Netupitant and Palonosetron Hydrochloride Capsules Product Portfolio
6.4.5 CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Recent Developments/Updates
6.5 QILU PHARMACEUTICAL CO.,LTD
6.5.1 QILU PHARMACEUTICAL CO.,LTD Company Information
6.5.2 QILU PHARMACEUTICAL CO.,LTD Description and Business Overview
6.5.3 QILU PHARMACEUTICAL CO.,LTD Netupitant and Palonosetron Hydrochloride Capsules Sales, Revenue and Gross Margin (2020-2025)
6.5.4 QILU PHARMACEUTICAL CO.,LTD Netupitant and Palonosetron Hydrochloride Capsules Product Portfolio
6.5.5 QILU PHARMACEUTICAL CO.,LTD Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Netupitant and Palonosetron Hydrochloride Capsules Industry Chain Analysis
7.2 Netupitant and Palonosetron Hydrochloride Capsules Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Netupitant and Palonosetron Hydrochloride Capsules Production Mode & Process Analysis
7.4 Netupitant and Palonosetron Hydrochloride Capsules Sales and Marketing
7.4.1 Netupitant and Palonosetron Hydrochloride Capsules Sales Channels
7.4.2 Netupitant and Palonosetron Hydrochloride Capsules Distributors
7.5 Netupitant and Palonosetron Hydrochloride Capsules Customer Analysis
8 Netupitant and Palonosetron Hydrochloride Capsules Market Dynamics
8.1 Netupitant and Palonosetron Hydrochloride Capsules Industry Trends
8.2 Netupitant and Palonosetron Hydrochloride Capsules Market Drivers
8.3 Netupitant and Palonosetron Hydrochloride Capsules Market Challenges
8.4 Netupitant and Palonosetron Hydrochloride Capsules Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
EurimPharm Arzneimittel GmbH
Sichuan Kelun Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group Co. Ltd
Qilu Pharmaceutical Co. Ltd.
Helsinn Birex Pharmaceuticals Ltd
List of Tables
 Table 1. Global Netupitant and Palonosetron Hydrochloride Capsules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Netupitant and Palonosetron Hydrochloride Capsules Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Netupitant and Palonosetron Hydrochloride Capsules Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Netupitant and Palonosetron Hydrochloride Capsules Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Netupitant and Palonosetron Hydrochloride Capsules, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Netupitant and Palonosetron Hydrochloride Capsules, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Netupitant and Palonosetron Hydrochloride Capsules, Product Type & Application
 Table 12. Global Key Manufacturers of Netupitant and Palonosetron Hydrochloride Capsules, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Netupitant and Palonosetron Hydrochloride Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Netupitant and Palonosetron Hydrochloride Capsules as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Netupitant and Palonosetron Hydrochloride Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Region (2020-2025) & (K Units)
 Table 18. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Region (2020-2025)
 Table 19. Global Netupitant and Palonosetron Hydrochloride Capsules Sales by Region (2026-2031) & (K Units)
 Table 20. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Region (2026-2031)
 Table 21. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Region (2020-2025)
 Table 23. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Region (2026-2031)
 Table 25. North America Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2020-2025) & (K Units)
 Table 27. North America Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2026-2031) & (K Units)
 Table 28. North America Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Netupitant and Palonosetron Hydrochloride Capsules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Netupitant and Palonosetron Hydrochloride Capsules Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Netupitant and Palonosetron Hydrochloride Capsules Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Netupitant and Palonosetron Hydrochloride Capsules Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Netupitant and Palonosetron Hydrochloride Capsules Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Netupitant and Palonosetron Hydrochloride Capsules Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Netupitant and Palonosetron Hydrochloride Capsules Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units) by Type (2020-2025)
 Table 51. Global Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units) by Type (2026-2031)
 Table 52. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Type (2020-2025)
 Table 53. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Type (2026-2031)
 Table 54. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Type (2020-2025)
 Table 57. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Type (2026-2031)
 Table 58. Global Netupitant and Palonosetron Hydrochloride Capsules Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Netupitant and Palonosetron Hydrochloride Capsules Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units) by Application (2020-2025)
 Table 61. Global Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units) by Application (2026-2031)
 Table 62. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Application (2020-2025)
 Table 63. Global Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Application (2026-2031)
 Table 64. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Application (2020-2025)
 Table 67. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Application (2026-2031)
 Table 68. Global Netupitant and Palonosetron Hydrochloride Capsules Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Netupitant and Palonosetron Hydrochloride Capsules Price (US$/Unit) by Application (2026-2031)
 Table 70. Helsinn Birex Pharmaceuticals Ltd Company Information
 Table 71. Helsinn Birex Pharmaceuticals Ltd Description and Business Overview
 Table 72. Helsinn Birex Pharmaceuticals Ltd Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Helsinn Birex Pharmaceuticals Ltd Netupitant and Palonosetron Hydrochloride Capsules Product
 Table 74. Helsinn Birex Pharmaceuticals Ltd Recent Developments/Updates
 Table 75. Eurimpharm Arzneimittel GmbH Company Information
 Table 76. Eurimpharm Arzneimittel GmbH Description and Business Overview
 Table 77. Eurimpharm Arzneimittel GmbH Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Eurimpharm Arzneimittel GmbH Netupitant and Palonosetron Hydrochloride Capsules Product
 Table 79. Eurimpharm Arzneimittel GmbH Recent Developments/Updates
 Table 80. Sichuan Kelun Pharmaceutical Co., Ltd Company Information
 Table 81. Sichuan Kelun Pharmaceutical Co., Ltd Description and Business Overview
 Table 82. Sichuan Kelun Pharmaceutical Co., Ltd Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sichuan Kelun Pharmaceutical Co., Ltd Netupitant and Palonosetron Hydrochloride Capsules Product
 Table 84. Sichuan Kelun Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 85. CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Company Information
 Table 86. CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Description and Business Overview
 Table 87. CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Netupitant and Palonosetron Hydrochloride Capsules Product
 Table 89. CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD Recent Developments/Updates
 Table 90. QILU PHARMACEUTICAL CO.,LTD Company Information
 Table 91. QILU PHARMACEUTICAL CO.,LTD Description and Business Overview
 Table 92. QILU PHARMACEUTICAL CO.,LTD Netupitant and Palonosetron Hydrochloride Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. QILU PHARMACEUTICAL CO.,LTD Netupitant and Palonosetron Hydrochloride Capsules Product
 Table 94. QILU PHARMACEUTICAL CO.,LTD Recent Developments/Updates
 Table 95. Key Raw Materials Lists
 Table 96. Raw Materials Key Suppliers Lists
 Table 97. Netupitant and Palonosetron Hydrochloride Capsules Distributors List
 Table 98. Netupitant and Palonosetron Hydrochloride Capsules Customers List
 Table 99. Netupitant and Palonosetron Hydrochloride Capsules Market Trends
 Table 100. Netupitant and Palonosetron Hydrochloride Capsules Market Drivers
 Table 101. Netupitant and Palonosetron Hydrochloride Capsules Market Challenges
 Table 102. Netupitant and Palonosetron Hydrochloride Capsules Market Restraints
 Table 103. Research Programs/Design for This Report
 Table 104. Key Data Information from Secondary Sources
 Table 105. Key Data Information from Primary Sources
 Table 106. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Netupitant and Palonosetron Hydrochloride Capsules
 Figure 2. Global Netupitant and Palonosetron Hydrochloride Capsules Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Netupitant and Palonosetron Hydrochloride Capsules Market Share by Type: 2024 & 2031
 Figure 4. 300 mg/Capsule 1 Capsule/Box Product Picture
 Figure 5. 0.5 mg/Capsule 1 Capsule/Box Product Picture
 Figure 6. Global Netupitant and Palonosetron Hydrochloride Capsules Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Netupitant and Palonosetron Hydrochloride Capsules Market Share by Application: 2024 & 2031
 Figure 8. Moderate Emetogenic Chemotherapy
 Figure 9. Highly Emetogenic Chemotherapy
 Figure 10. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Netupitant and Palonosetron Hydrochloride Capsules Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Netupitant and Palonosetron Hydrochloride Capsules Sales (2020-2031) & (K Units)
 Figure 13. Global Netupitant and Palonosetron Hydrochloride Capsules Average Price (US$/Unit) & (2020-2031)
 Figure 14. Netupitant and Palonosetron Hydrochloride Capsules Report Years Considered
 Figure 15. Netupitant and Palonosetron Hydrochloride Capsules Sales Share by Manufacturers in 2024
 Figure 16. Global Netupitant and Palonosetron Hydrochloride Capsules Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Netupitant and Palonosetron Hydrochloride Capsules Players: Market Share by Revenue in Netupitant and Palonosetron Hydrochloride Capsules in 2024
 Figure 18. Netupitant and Palonosetron Hydrochloride Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Netupitant and Palonosetron Hydrochloride Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Country (2020-2031)
 Figure 21. North America Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Country (2020-2031)
 Figure 22. United States Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Country (2020-2031)
 Figure 25. Europe Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Region (2020-2031)
 Figure 33. China Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Latin America Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Country (2020-2031)
 Figure 41. Latin America Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Country (2020-2031)
 Figure 42. Mexico Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Brazil Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Argentina Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Middle East and Africa Netupitant and Palonosetron Hydrochloride Capsules Sales Market Share by Country (2020-2031)
 Figure 46. Middle East and Africa Netupitant and Palonosetron Hydrochloride Capsules Revenue Market Share by Country (2020-2031)
 Figure 47. Turkey Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. UAE Netupitant and Palonosetron Hydrochloride Capsules Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Global Sales Market Share of Netupitant and Palonosetron Hydrochloride Capsules by Type (2020-2031)
 Figure 51. Global Revenue Market Share of Netupitant and Palonosetron Hydrochloride Capsules by Type (2020-2031)
 Figure 52. Global Netupitant and Palonosetron Hydrochloride Capsules Price (US$/Unit) by Type (2020-2031)
 Figure 53. Global Sales Market Share of Netupitant and Palonosetron Hydrochloride Capsules by Application (2020-2031)
 Figure 54. Global Revenue Market Share of Netupitant and Palonosetron Hydrochloride Capsules by Application (2020-2031)
 Figure 55. Global Netupitant and Palonosetron Hydrochloride Capsules Price (US$/Unit) by Application (2020-2031)
 Figure 56. Netupitant and Palonosetron Hydrochloride Capsules Value Chain
 Figure 57. Channels of Distribution (Direct Vs Distribution)
 Figure 58. Bottom-up and Top-down Approaches for This Report
 Figure 59. Data Triangulation
 Figure 60. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Netupitant Palonosetron FDC Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Palonosetron HCl API Market Research Report 2024
Global Palonosetron Market Insights Forecast to 2030
Global Palonosetron Hydrochloride Injection Market Research Report 2025
Global Palonosetron Hydrochloride Market Research Report 2024
Palonosetron HCI Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Ramosetron Market Research Report 2024
Palonosetron Hydrochloride API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Aprepitant Preparations Market Research Report 2024
Global Maropitant Citrate Market Research Report 2024
Global Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Insights Forecast to 2030
Global Maropitant Citrate Tablets Market Research Report 2024
Global Chemotheraphy Induced Nausea and Vomitting CINV Drugs Market Insights Forecast to 2030
Chemotherapy induced Nausea and Vomiting Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Vebreltinib Enteric Capsules Market Research Report 2024
Global Ondansetron Hydrochloride Injection Market Research Report 2024
Global Ziprasidone Hydrochloride Capsules Market Research Report 2024
Global Granisetron Market Insights Forecast to 2030
Global Treatment of Chemotherapy Induced Nausea in Cancer Patients Market Research Report 2025
Global Ciclosporin Soft Capsules Market Research Report 2024

RELATED REPORTS

Global Hormonal Therapy for Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-5L19798
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Cancer Insurance Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28I6901
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Induced Myeloid Leukemia Cell Differentiation Protein Mcl 1 Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22R9736
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Drugs for Differentiated Thyroid Cancer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29A2598
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions